Full PBPK model |
- Parameters |
K
0 (M/h) |
Endogenous IgG production rate |
(13) |
Q
organ (L/h) |
Plasma Flow rate to each organ |
(10) |
L
organ (L/h) |
Lymphatic Flow rate to each organ |
(10) |
CLOrganUptake (L/h) |
Endosomal uptake rate of unbound antibody |
(13) |
CLOrganProteolysis (L/h) |
Clearance rate of unbound antibody via proteolytic degradation in the endosome |
Same value for CL
OrganUptake. |
k
on-X (M−1 h−1) |
mAb-FcRn association constant in each subendosomal compartment X
|
(13) Assumed similar for IgG and mAb |
k
off-X (h−1) |
mAb-FcRn dissociation constant in each subendosomal compartment X
|
(13) Assumed similar for IgG and mAb |
KA (M)−1
|
Equilibrium binding association affinity |
|
RtotalOrgan ‐ X (moles) |
Initial amount of free FcRn receptor in subendosomal compartment X
|
obtained by multiplying FcRn concentration reported in (13) by V
OrganEND
|
F
return (no units) |
Fraction of antibody returning from lymph node to plasma |
(13) |
τ (h) |
Transit time between endosomal compartments |
(13) (0.045) |
TauLN (h) |
Transit time from lymph node to plasma |
(13) (9.1) |
σ
VAS (no unit) |
Vascular reflection coefficient |
Same for all organs (0.95) (11) |
σ
LY (no unit) |
Lymph reflection coefficient |
Same for all organs (0.2) |
FR (no unit) |
Recycling fraction of the bound antibody from endosomal to vascular and interstitial subcompartments |
(11) (0.715) |
V
OrganVAS (L) |
Volume of vascular compartment in each organ |
(11) |
V
OrganISF (L) |
Volume of interstitial compartment in each organ |
(11) |
V
OrganEND (L) |
Volume of each endosomal subcompartment in each organ |
(11) |
V
Plasma (L) |
Volume of plasma |
(11) |
- Variables |
A
JPlasma (moles) |
Amount of endogenous IgG or mAb in plasma |
|
A
JLN (moles) |
Amount of endogenous IgG or mAb in lymph node |
|
A
JVAS Organ (moles) |
Amount of endogenous IgG or mAb in vascular space |
|
A
JISF Organ (moles) |
Amount of endogenous IgG or mAb in interstitial space |
|
A
JEND Organ ‐ X (moles) |
Amount of endogenous IgG or mAb in subendosomal compartment X
|
|
ARCPXJOrgan ‐ X (moles) |
Amount of endogenous IgG -FcRn or mAb-FcRn receptor complex in subendosomal compartment X
|
|
Step 1 (Fig. 2) |
- Parameters |
k
OrganVAS ‐ circul. (h−1) |
Transfer rate from vascular compartment to lung or, in case of lung, from lung to plasma |
|
k
Organcircul. ‐ VAS (h−1) |
Transfer rate from plasma to vascular compartment |
|
(1 − σ
VAS) × k
OrganLY VAS ‐ ISF (h−1) |
Transfer from vascular to interstitial compartment via lymphatic flow |
|
k
OrganVAS ‐ EL (h−1) |
Elimination from vascular compartment |
|
k
OrganVAS ‐ VAS (h−1) |
Input from vascular compartment to itself. Reflect endosomal contribution to vascular compartment |
|
k
OrganVAS ‐ ISF (h−1) |
Transfer from vascular to interstitial compartment |
|
k
OrganISF ‐ VAS (h−1) |
Transfer from interstitial to vascular compartment |
|
(1 − σ
LY) × k
OrganLY ISF ‐ LN (h−1) |
Transfer from interstitial compartment to lymph node via lymphatic flow |
|
k
OrganISF ‐ EL (h−1) |
Elimination from interstitial compartment |
|
k
OrganISF ‐ ISF (h−1) |
Input from interstitial compartment to itself. Reflect endosomal contribution to interstitial compartment |
|
KDEND (moles) |
Equilibrium dissociation constant for mAb binding to FcRn receptor in amounts |
|
K
0 (M/h) |
Endogenous IgG production rate |
(13) |
- Variables |
A
JEND Total Organ ‐ X (moles) |
Total amount of endogenous IgG or mAb (bound and free) in subendosomal compartment X
|
|
Steps 2 and 3 (Fig. 3a and b) |
- Parameters |
Q
Visceral (L/h) |
plasma Flow rate to the visceral compartment |
Q
Heart + Q
Kidney + Q
Skin + Q
Muscle
|
Q
Splanchnic (L/h) |
plasma Flow rate to the splanchnic compartment |
Q
GIT + Q
Spleen
|
L
Visceral (L/h) |
Lymph Flow rate to the visceral compartment |
L
Heart + L
Kidney + L
Skin + L
Muscle
|
L
Splanchnic (L/h) |
Lymph Flow rate to the splanchnic compartment |
L
GIT + L
Spleen
|
- New compartments resulting from model simplification |
Splanchnic
|
GIT and spleen |
|
Visceral
|
Heart, kidney, skin, and muscle lumped |
|
Steps 4, and 5 (Fig. 3c and d) |
- Parameters |
Q
Peripheral (L/h) |
Plasma Flow rate to the Peripheral compartment |
Q
Visceral + Q
Splanchnic
|
L
Peripheral (L/h) |
Lymph Flow rate to the Peripheral compartment |
L
Visceral + L
Splanchnic
|
- New compartments resulting from lumping |
|
Peripheral
|
Visceral and splanchnic |
|
Step 6 (Fig. 3e) |
- Parameters |
k
CentralEL (h−1) |
Elimination rate from the central compartment |
|
(1 − σ
VAS) × k
CentralLY Central ‐ Per (h−1) |
Transfer rate from the central to interstitial (i.e., peripheral) compartment via lymphatic flow |
|
k
CentralCentral (h−1) |
First-order input from central compartment to itself which reflects the impact of recycled drug from endosomal compartment |
|
k
CentralCentral ‐ ISF (h−1) |
First-order input from central to interstitial (i.e., peripheral) compartment |
|
k
PeripheralISF ‐ Central (h−1) |
Transfer from interstitial (i.e., peripheral) to central compartments |
|
(1 − σ
LY) × k
PeripheralLY ISF ‐ LN (h−1) |
Transfer from interstitial (i.e., peripheral) compartment to lymph node via lymphatic flow |
|
k
PeripheralISF ‐ ISF (h−1) |
Input from Peripheral compartment to itself. Reflect endosomal contribution to interstitial compartment |
|
(h−1) |
Transfer from lymph node to Central compartment |
|
Variables |
A
Central (moles) |
Amount of mAb in the central compartment (i.e., plasma and Vascular subcompartments in equilibrium) |
|
A
Peripheral (moles) |
Amount of mAb in the Peripheral compartment |
|
Step 7 (Fig. 3f) |
- Parameters |
k
CEL (h−1) |
Elimination rate from the central compartment after subtracting the contribution of the endosomal compartment |
|
k
PEL (h−1) |
Elimination rate from the peripheral compartment after subtracting the contribution of the endosomal compartment |
|
k
Cen ‐ Per (h−1) |
Reflection of the fraction mAb-FcRn complex recycled |
|
(1 − σ
VAS) × k
CentralLY ‐ ISF (h−1) |
Transfer of the mAb from Central to Peripheral compartments via lymphatic flow |
|
k
CP (h−1) |
Transfer of the mAb from Central to Peripheral compartments via two processes, a- the lymphatic flow and b- the reflection of the fraction mAb-FcRn complex recycled |
(1 − σ
VAS) × k
CentralLY ‐ ISF + k
CentralCentral ‐ ISF
|
(1 − σ
LY) × k
PeripheralLY ISF ‐ LN (h−1) |
Transfer from interstitial (i.e., peripheral) compartment to lymph node via lymphatic flow |
|
(h−1) |
Transfer from lymph node to Central compartment |
|
Final simplified model (Fig. 4) |
- Parameters |
V
C (L) |
Volume of the Central Compartment |
|
k
EL (h−1) |
Elimination rate from the central and peripheral compartments |
|
k
CP (h−1) |
Transfer of the mAb from Central to Peripheral compartments via two processes, a- the lymphatic flow and b- the reflection of the fraction mAb-FcRn complex recycled |
(1 − σ
VAS) ∗ k
CentralLY − ISF + k
CentralCentral − ISF
|
k
LN (h−1) |
Transfer from interstitial (i.e., peripheral) compartment to lymph node via lymphatic flow and Transfer from lymph node to Central compartment |
|